Is Revvity, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Revvity, Inc. moved from fair to very expensive, indicating a significant shift in its perceived value. The company appears overvalued based on its current metrics, with a P/E ratio of 33, an EV to EBITDA of 15.29, and a PEG ratio of 3.05. In comparison, Hologic, Inc. has a fair valuation with a P/E of 21.83, while The Cooper Companies, Inc. is considered expensive with a P/E of 34.28, highlighting that Revvity's valuation is on the higher end relative to its peers.
Recent stock performance shows that Revvity has underperformed compared to the S&P 500, with a year-to-date return of -16.30% versus the S&P 500's 13.30%. This trend continues over longer periods, with a 5-year return of -24.67% compared to the S&P 500's 91.29%, reinforcing the notion that Revvity, Inc. is currently overvalued.